Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance.
about
Genome-wide analysis of microRNA and mRNA expression signatures in cancerMicro-RNAs as diagnostic or prognostic markers in human epithelial malignanciesMicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancerGenome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cellsNon-coding RNAs and gastric cancerMicroRNA profiles discriminate among colon cancer metastasis.microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathwaymiR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesisMiRNA as potential biomarkers and therapeutic targets for gastric cancer.MicroRNAs as potential biomarkers for gastric cancer.Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis.Overexpression of E2F mRNAs associated with gastric cancer progression identified by the transcription factor and miRNA co-regulatory network analysis.Identification of a circulating microRNA signature for colorectal cancer detection.Allelic imbalance in the miR-31 host gene locus in lung cancer--its potential role in carcinogenesis.The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTENGastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.Current trends in miRNAs and their relationship with oral squamous cell carcinoma.Control of metastatic progression by microRNA regulatory networks.Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC).Epigenetic biomarkers: potential applications in gastrointestinal cancersRole of miRNA in head and neck squamous cell carcinoma.Identification of Aberrantly Expressed miRNAs in Gastric Cancer.MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.Epigenetic Biomarkers for the Early Detection of Gastrointestinal Cancer.MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoAAssociation of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex.miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1.Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells.Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells.MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.Expression and significance of circulating microRNA-31 in lung cancer patients.Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway.
P2860
Q26795603-BC37F4D9-B182-4837-8395-0F8B879D8552Q26823077-9E9D7883-96D5-452B-9D52-C5DF91757D9FQ27022048-06B66AD8-7E8F-4088-9DF9-A4AA0F3EF5E7Q33565717-1BBF922F-76AF-4FB9-A489-3BE7BCA3D8EAQ33594919-9973656E-E7C2-43F5-9E28-8A7589BAFE7BQ33748980-2001304C-A56D-4030-8273-3BC616A52139Q33792672-0E2FF8F3-AF23-4EC2-A1CF-4134A5300272Q34023389-97235568-F6DB-43D3-B8A2-6237B8AF3D82Q34036679-049A0DF8-1213-493A-A859-265B27C2EB16Q34168445-6635A52F-23AE-4830-9FC2-19775E0ADFE9Q34217592-201DD37C-1396-481D-BBCA-ECB44146ED17Q34984342-E9E7E78B-4B25-4AB5-B33C-4595F4FBCEA0Q35043503-254EF5D7-2EBA-4A26-B023-2FBD832F6056Q35141718-4C303183-1547-49C4-8946-6F1DA32D6AF2Q35198062-DAC42FF6-2995-4333-9CAC-8575467C0425Q36158807-85948C51-D92F-4AC2-9958-6B96AA58242DQ36642781-E5118BC7-5737-43A9-8D4E-DEC9A3A8A92BQ37063944-11FB0DF7-7020-40B0-9ED2-191A5649B1FDQ37799873-BF2E25C6-BFE1-4723-94F8-7CBBFFC95843Q37970449-484F2C40-E27A-4BD3-85F2-9CEFD1906161Q38111225-649E5DB8-9086-4CA0-B6DB-E4097D5E6B1AQ38115621-61E94DD9-A7B9-462C-A018-454C1317F87DQ38166570-A4BA97F7-28F4-4C74-A1F1-9BE2372078CDQ38204377-E308FD38-2854-41F5-A753-664C44696EBFQ38264776-08312614-0DCC-4CE7-800E-F08AAC455FD4Q38475359-C61D7017-E7DF-4F91-958E-6A13AF775F4AQ38496364-708F1944-0760-44E6-95FE-347026B40169Q38637829-2BF8DF15-EA1F-436C-AA30-13D6A9FAC49AQ38671092-8DF306AD-EEE7-4ABB-B703-A5A607239E2BQ38728171-8BF2EA72-5101-47FD-965B-EBA7B0F081FAQ38932418-AA43AE7F-F5A0-4421-992C-60D6ED01DD61Q38985720-D8317D2D-034B-4181-99DA-DC9144A12FC2Q39063655-4B69FD7C-C63E-4CA4-A3A2-C6D61B4F010AQ39285644-F7287765-4BB0-49DE-BD3F-180DDF2987DBQ39394724-DAF12E61-45A8-4F6E-A74C-6DD718E877B9Q39634084-B139D180-849F-464F-90B0-234229385A86Q40581942-C4066554-208F-46B7-8F2D-CF51D80DA346Q41987857-74F17CD6-4FA5-4B8D-A89D-E406DBC6C63AQ47101112-B8453A33-9D1F-4DB6-A6F2-D3305E369E65Q47123705-ED9499C6-C242-42AB-BFC5-A95625F7FD18
P2860
Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Down-regulation of miR-31 expr ...... and its clinical significance.
@ast
Down-regulation of miR-31 expr ...... and its clinical significance.
@en
Down-regulation of miR-31 expr ...... and its clinical significance.
@nl
type
label
Down-regulation of miR-31 expr ...... and its clinical significance.
@ast
Down-regulation of miR-31 expr ...... and its clinical significance.
@en
Down-regulation of miR-31 expr ...... and its clinical significance.
@nl
prefLabel
Down-regulation of miR-31 expr ...... and its clinical significance.
@ast
Down-regulation of miR-31 expr ...... and its clinical significance.
@en
Down-regulation of miR-31 expr ...... and its clinical significance.
@nl
P2093
P1433
P1476
Down-regulation of miR-31 expr ...... and its clinical significance.
@en
P2093
Bingxiu Xiao
Junming Guo
Yuanyuan Zhang
Zhen Jiang
P2860
P2888
P304
P356
10.1007/S12032-009-9269-X
P577
2009-07-14T00:00:00Z
P5875
P6179
1051041895